nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminosalicylic Acid—MPO—chronic obstructive pulmonary disease	0.475	1	CbGaD
Aminosalicylic Acid—ALOX5—Montelukast—chronic obstructive pulmonary disease	0.296	0.816	CbGbCtD
Aminosalicylic Acid—PTGS1—Montelukast—chronic obstructive pulmonary disease	0.0665	0.184	CbGbCtD
Aminosalicylic Acid—CHUK—connective tissue—chronic obstructive pulmonary disease	0.00255	0.115	CbGeAlD
Aminosalicylic Acid—PTGS2—leg—chronic obstructive pulmonary disease	0.00252	0.114	CbGeAlD
Aminosalicylic Acid—Abdominal bloating—Salbutamol—chronic obstructive pulmonary disease	0.00192	0.0277	CcSEcCtD
Aminosalicylic Acid—Peptic ulcer—Aminophylline—chronic obstructive pulmonary disease	0.0019	0.0275	CcSEcCtD
Aminosalicylic Acid—ALOX5—respiratory system—chronic obstructive pulmonary disease	0.00163	0.0738	CbGeAlD
Aminosalicylic Acid—CHUK—lung—chronic obstructive pulmonary disease	0.00154	0.0696	CbGeAlD
Aminosalicylic Acid—ALOX5—connective tissue—chronic obstructive pulmonary disease	0.00143	0.065	CbGeAlD
Aminosalicylic Acid—MPO—respiratory system—chronic obstructive pulmonary disease	0.00138	0.0624	CbGeAlD
Aminosalicylic Acid—ALOX5—bronchus—chronic obstructive pulmonary disease	0.00134	0.0607	CbGeAlD
Aminosalicylic Acid—ALOX5—smooth muscle tissue—chronic obstructive pulmonary disease	0.00131	0.0594	CbGeAlD
Aminosalicylic Acid—Dermatitis atopic—Montelukast—chronic obstructive pulmonary disease	0.00128	0.0185	CcSEcCtD
Aminosalicylic Acid—MPO—connective tissue—chronic obstructive pulmonary disease	0.00121	0.055	CbGeAlD
Aminosalicylic Acid—Weight decreased—Roflumilast—chronic obstructive pulmonary disease	0.00108	0.0156	CcSEcCtD
Aminosalicylic Acid—Mesalazine—MPO—chronic obstructive pulmonary disease	0.000986	0.457	CrCbGaD
Aminosalicylic Acid—Dermatitis exfoliative—Aminophylline—chronic obstructive pulmonary disease	0.000978	0.0141	CcSEcCtD
Aminosalicylic Acid—Vasculitis—Montelukast—chronic obstructive pulmonary disease	0.000971	0.014	CcSEcCtD
Aminosalicylic Acid—ALOX5—lung—chronic obstructive pulmonary disease	0.000866	0.0392	CbGeAlD
Aminosalicylic Acid—Optic neuritis—Prednisolone—chronic obstructive pulmonary disease	0.000852	0.0123	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Roflumilast—chronic obstructive pulmonary disease	0.000833	0.012	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Roflumilast—chronic obstructive pulmonary disease	0.000816	0.0118	CcSEcCtD
Aminosalicylic Acid—Peptic ulcer—Prednisolone—chronic obstructive pulmonary disease	0.000784	0.0113	CcSEcCtD
Aminosalicylic Acid—MPO—lung—chronic obstructive pulmonary disease	0.000732	0.0332	CbGeAlD
Aminosalicylic Acid—Hypoglycaemia—Arformoterol—chronic obstructive pulmonary disease	0.000719	0.0104	CcSEcCtD
Aminosalicylic Acid—Hypoglycaemia—Formoterol—chronic obstructive pulmonary disease	0.000719	0.0104	CcSEcCtD
Aminosalicylic Acid—Dermatitis atopic—Prednisolone—chronic obstructive pulmonary disease	0.000708	0.0102	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Roflumilast—chronic obstructive pulmonary disease	0.000704	0.0102	CcSEcCtD
Aminosalicylic Acid—Hypoglycaemia—Salbutamol—chronic obstructive pulmonary disease	0.000679	0.00981	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Roflumilast—chronic obstructive pulmonary disease	0.000667	0.00963	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Roflumilast—chronic obstructive pulmonary disease	0.00066	0.00954	CcSEcCtD
Aminosalicylic Acid—PTGS1—respiratory system—chronic obstructive pulmonary disease	0.000654	0.0296	CbGeAlD
Aminosalicylic Acid—PTGS2—respiratory system—chronic obstructive pulmonary disease	0.000625	0.0283	CbGeAlD
Aminosalicylic Acid—Optic neuritis—Prednisone—chronic obstructive pulmonary disease	0.000619	0.00894	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Tiotropium—chronic obstructive pulmonary disease	0.000594	0.00858	CcSEcCtD
Aminosalicylic Acid—Hypothyroidism—Prednisone—chronic obstructive pulmonary disease	0.000593	0.00856	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.000591	0.00854	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Tiotropium—chronic obstructive pulmonary disease	0.00059	0.00852	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.000587	0.00848	CcSEcCtD
Aminosalicylic Acid—Abdominal distension—Salbutamol—chronic obstructive pulmonary disease	0.000577	0.00833	CcSEcCtD
Aminosalicylic Acid—PTGS1—connective tissue—chronic obstructive pulmonary disease	0.000576	0.0261	CbGeAlD
Aminosalicylic Acid—Peptic ulcer—Prednisone—chronic obstructive pulmonary disease	0.000569	0.00822	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.000556	0.00803	CcSEcCtD
Aminosalicylic Acid—PTGS2—connective tissue—chronic obstructive pulmonary disease	0.000551	0.0249	CbGeAlD
Aminosalicylic Acid—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.00054	0.0078	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.000537	0.00776	CcSEcCtD
Aminosalicylic Acid—Vasculitis—Prednisolone—chronic obstructive pulmonary disease	0.000537	0.00775	CcSEcCtD
Aminosalicylic Acid—PTGS1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000527	0.0239	CbGeAlD
Aminosalicylic Acid—Malnutrition—Tiotropium—chronic obstructive pulmonary disease	0.000524	0.00757	CcSEcCtD
Aminosalicylic Acid—Droxidopa—ADRB2—chronic obstructive pulmonary disease	0.00052	0.241	CrCbGaD
Aminosalicylic Acid—Neuropathy peripheral—Montelukast—chronic obstructive pulmonary disease	0.000519	0.0075	CcSEcCtD
Aminosalicylic Acid—Jaundice—Montelukast—chronic obstructive pulmonary disease	0.000517	0.00746	CcSEcCtD
Aminosalicylic Acid—PTGS2—bronchus—chronic obstructive pulmonary disease	0.000515	0.0233	CbGeAlD
Aminosalicylic Acid—Dermatitis atopic—Prednisone—chronic obstructive pulmonary disease	0.000514	0.00743	CcSEcCtD
Aminosalicylic Acid—PTGS2—smooth muscle tissue—chronic obstructive pulmonary disease	0.000504	0.0228	CbGeAlD
Aminosalicylic Acid—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.000501	0.00723	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Salbutamol—chronic obstructive pulmonary disease	0.000501	0.00723	CcSEcCtD
Aminosalicylic Acid—Jaundice—Salbutamol—chronic obstructive pulmonary disease	0.000498	0.00719	CcSEcCtD
Aminosalicylic Acid—PTGS1—trachea—chronic obstructive pulmonary disease	0.000484	0.0219	CbGeAlD
Aminosalicylic Acid—Urinary tract disorder—Formoterol—chronic obstructive pulmonary disease	0.00048	0.00693	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Arformoterol—chronic obstructive pulmonary disease	0.00048	0.00693	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Arformoterol—chronic obstructive pulmonary disease	0.000476	0.00688	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Formoterol—chronic obstructive pulmonary disease	0.000476	0.00688	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Montelukast—chronic obstructive pulmonary disease	0.000476	0.00687	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Montelukast—chronic obstructive pulmonary disease	0.00047	0.00679	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Montelukast—chronic obstructive pulmonary disease	0.000466	0.00674	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000465	0.00672	CcSEcCtD
Aminosalicylic Acid—PTGS2—trachea—chronic obstructive pulmonary disease	0.000462	0.0209	CbGeAlD
Aminosalicylic Acid—Urinary tract disorder—Salbutamol—chronic obstructive pulmonary disease	0.000453	0.00654	CcSEcCtD
Aminosalicylic Acid—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00045	0.00649	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Salbutamol—chronic obstructive pulmonary disease	0.00045	0.00649	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.000445	0.00642	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.000443	0.0064	CcSEcCtD
Aminosalicylic Acid—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000432	0.00624	CcSEcCtD
Aminosalicylic Acid—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.000432	0.00624	CcSEcCtD
Aminosalicylic Acid—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000429	0.00619	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000428	0.00619	CcSEcCtD
Aminosalicylic Acid—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000426	0.00615	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Formoterol—chronic obstructive pulmonary disease	0.000423	0.00611	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Arformoterol—chronic obstructive pulmonary disease	0.000423	0.00611	CcSEcCtD
Aminosalicylic Acid—Diflunisal—ALB—chronic obstructive pulmonary disease	0.00042	0.194	CrCbGaD
Aminosalicylic Acid—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000419	0.00606	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.000415	0.006	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.000414	0.00598	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	0.000414	0.00598	CcSEcCtD
Aminosalicylic Acid—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000404	0.00583	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.000399	0.00577	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000394	0.00569	CcSEcCtD
Aminosalicylic Acid—Flatulence—Salbutamol—chronic obstructive pulmonary disease	0.000393	0.00568	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.000391	0.00565	CcSEcCtD
Aminosalicylic Acid—Vasculitis—Prednisone—chronic obstructive pulmonary disease	0.00039	0.00563	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000371	0.00535	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000369	0.00533	CcSEcCtD
Aminosalicylic Acid—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00036	0.0052	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000358	0.00518	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000358	0.00518	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000357	0.00516	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000357	0.00516	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.00035	0.00506	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00035	0.00505	CcSEcCtD
Aminosalicylic Acid—PTGS1—lung—chronic obstructive pulmonary disease	0.000347	0.0157	CbGeAlD
Aminosalicylic Acid—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00034	0.00491	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000338	0.00489	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000338	0.00489	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000338	0.00488	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000335	0.00484	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000335	0.00484	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000334	0.00482	CcSEcCtD
Aminosalicylic Acid—PTGS2—lung—chronic obstructive pulmonary disease	0.000332	0.015	CbGeAlD
Aminosalicylic Acid—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000331	0.00479	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000331	0.00478	CcSEcCtD
Aminosalicylic Acid—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.000331	0.00478	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000328	0.00474	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00032	0.00461	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000316	0.00457	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000315	0.00455	CcSEcCtD
Aminosalicylic Acid—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000311	0.00449	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00031	0.00448	CcSEcCtD
Aminosalicylic Acid—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.000309	0.00446	CcSEcCtD
Aminosalicylic Acid—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.0003	0.00433	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000298	0.0043	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000298	0.0043	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000292	0.00421	CcSEcCtD
Aminosalicylic Acid—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000288	0.00416	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000287	0.00415	CcSEcCtD
Aminosalicylic Acid—Purpura—Prednisone—chronic obstructive pulmonary disease	0.000287	0.00414	CcSEcCtD
Aminosalicylic Acid—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000286	0.00413	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000286	0.00412	CcSEcCtD
Aminosalicylic Acid—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000284	0.0041	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000283	0.00409	CcSEcCtD
Aminosalicylic Acid—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000283	0.00408	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000282	0.00408	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000282	0.00408	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000281	0.00406	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000276	0.00399	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000276	0.00399	CcSEcCtD
Aminosalicylic Acid—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000274	0.00396	CcSEcCtD
Aminosalicylic Acid—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000274	0.00396	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000273	0.00394	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000273	0.00394	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000273	0.00394	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000273	0.00394	CcSEcCtD
Aminosalicylic Acid—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000272	0.00393	CcSEcCtD
Aminosalicylic Acid—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00027	0.00389	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000269	0.00389	CcSEcCtD
Aminosalicylic Acid—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000269	0.00389	CcSEcCtD
Aminosalicylic Acid—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000269	0.00388	CcSEcCtD
Aminosalicylic Acid—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000268	0.00387	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000267	0.00386	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000267	0.00386	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000266	0.00385	CcSEcCtD
Aminosalicylic Acid—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000259	0.00374	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000258	0.00372	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000258	0.00372	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000254	0.00367	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000254	0.00367	CcSEcCtD
Aminosalicylic Acid—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000254	0.00367	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000249	0.0036	CcSEcCtD
Aminosalicylic Acid—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.00024	0.00347	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00024	0.00347	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000236	0.00341	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000236	0.00341	CcSEcCtD
Aminosalicylic Acid—Salicylic acid—ALB—chronic obstructive pulmonary disease	0.000233	0.108	CrCbGaD
Aminosalicylic Acid—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000231	0.00334	CcSEcCtD
Aminosalicylic Acid—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000228	0.0033	CcSEcCtD
Aminosalicylic Acid—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000228	0.0033	CcSEcCtD
Aminosalicylic Acid—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000224	0.00323	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000223	0.00322	CcSEcCtD
Aminosalicylic Acid—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000219	0.00317	CcSEcCtD
Aminosalicylic Acid—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000219	0.00317	CcSEcCtD
Aminosalicylic Acid—Rash—Formoterol—chronic obstructive pulmonary disease	0.000218	0.00314	CcSEcCtD
Aminosalicylic Acid—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000218	0.00314	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000217	0.00314	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000217	0.00314	CcSEcCtD
Aminosalicylic Acid—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000216	0.00312	CcSEcCtD
Aminosalicylic Acid—Headache—Formoterol—chronic obstructive pulmonary disease	0.000216	0.00312	CcSEcCtD
Aminosalicylic Acid—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000216	0.00312	CcSEcCtD
Aminosalicylic Acid—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000215	0.00311	CcSEcCtD
Aminosalicylic Acid—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000215	0.0031	CcSEcCtD
Aminosalicylic Acid—Rash—Montelukast—chronic obstructive pulmonary disease	0.000213	0.00308	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000213	0.00307	CcSEcCtD
Aminosalicylic Acid—Headache—Montelukast—chronic obstructive pulmonary disease	0.000212	0.00306	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000209	0.00301	CcSEcCtD
Aminosalicylic Acid—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000207	0.00299	CcSEcCtD
Aminosalicylic Acid—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000205	0.00297	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000205	0.00296	CcSEcCtD
Aminosalicylic Acid—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000205	0.00296	CcSEcCtD
Aminosalicylic Acid—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000205	0.00296	CcSEcCtD
Aminosalicylic Acid—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000204	0.00295	CcSEcCtD
Aminosalicylic Acid—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000201	0.0029	CcSEcCtD
Aminosalicylic Acid—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000194	0.0028	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000166	0.0024	CcSEcCtD
Aminosalicylic Acid—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000154	0.00222	CcSEcCtD
Aminosalicylic Acid—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000148	0.00214	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000141	0.00203	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000138	0.00199	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000133	0.00192	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000132	0.00191	CcSEcCtD
Aminosalicylic Acid—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000129	0.00187	CcSEcCtD
Aminosalicylic Acid—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000124	0.00178	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000118	0.0017	CcSEcCtD
Aminosalicylic Acid—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000118	0.0017	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000118	0.0017	CcSEcCtD
Aminosalicylic Acid—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000117	0.00169	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000111	0.0016	CcSEcCtD
Aminosalicylic Acid—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000111	0.0016	CcSEcCtD
Aminosalicylic Acid—ALOX5—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000111	0.00159	CbGpPWpGaD
Aminosalicylic Acid—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000108	0.00156	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000107	0.00155	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000107	0.00155	CcSEcCtD
Aminosalicylic Acid—ALOX5—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	0.000107	0.00153	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—ERBB3—chronic obstructive pulmonary disease	0.000106	0.00152	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—ERBB3—chronic obstructive pulmonary disease	0.000106	0.00152	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—ERBB3—chronic obstructive pulmonary disease	0.000106	0.00152	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—ERBB3—chronic obstructive pulmonary disease	0.000105	0.00151	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—ERBB3—chronic obstructive pulmonary disease	0.000104	0.0015	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TCR Signaling Pathway—IL1B—chronic obstructive pulmonary disease	0.000104	0.00149	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—ERBB3—chronic obstructive pulmonary disease	0.000104	0.00149	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—HDAC2—chronic obstructive pulmonary disease	0.000104	0.00149	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—chronic obstructive pulmonary disease	0.000103	0.00148	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000103	0.00147	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000102	0.00146	CbGpPWpGaD
Aminosalicylic Acid—CHUK—AGE/RAGE pathway—EGFR—chronic obstructive pulmonary disease	0.000102	0.00146	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	0.000101	0.00144	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Rac1/Pak1/p38/MMP-2 pathway—EGFR—chronic obstructive pulmonary disease	0.0001	0.00144	CbGpPWpGaD
Aminosalicylic Acid—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.0001	0.00144	CcSEcCtD
Aminosalicylic Acid—ALOX5—Metabolism—GC—chronic obstructive pulmonary disease	9.99e-05	0.00143	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—ERBB3—chronic obstructive pulmonary disease	9.83e-05	0.00141	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll-like Receptor Signaling Pathway—CXCL8—chronic obstructive pulmonary disease	9.82e-05	0.00141	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	9.73e-05	0.0014	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	9.73e-05	0.0014	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Selenium Micronutrient Network—ALB—chronic obstructive pulmonary disease	9.71e-05	0.00139	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.66e-05	0.00139	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—KL—chronic obstructive pulmonary disease	9.65e-05	0.00138	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	9.6e-05	0.00138	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.52e-05	0.00137	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll-like Receptor Signaling Pathway—IL1B—chronic obstructive pulmonary disease	9.42e-05	0.00135	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—ERBB3—chronic obstructive pulmonary disease	9.41e-05	0.00135	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	9.29e-05	0.00133	CbGpPWpGaD
Aminosalicylic Acid—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	9.29e-05	0.00134	CcSEcCtD
Aminosalicylic Acid—CHUK—Signaling by Interleukins—IL1B—chronic obstructive pulmonary disease	8.99e-05	0.00129	CbGpPWpGaD
Aminosalicylic Acid—Dizziness—Prednisone—chronic obstructive pulmonary disease	8.98e-05	0.0013	CcSEcCtD
Aminosalicylic Acid—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	8.93e-05	0.00128	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.87e-05	0.00127	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	8.82e-05	0.00126	CbGpPWpGaD
Aminosalicylic Acid—Vomiting—Prednisone—chronic obstructive pulmonary disease	8.63e-05	0.00125	CcSEcCtD
Aminosalicylic Acid—Rash—Prednisone—chronic obstructive pulmonary disease	8.56e-05	0.00124	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Prednisone—chronic obstructive pulmonary disease	8.55e-05	0.00124	CcSEcCtD
Aminosalicylic Acid—CHUK—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—chronic obstructive pulmonary disease	8.55e-05	0.00123	CbGpPWpGaD
Aminosalicylic Acid—Headache—Prednisone—chronic obstructive pulmonary disease	8.51e-05	0.00123	CcSEcCtD
Aminosalicylic Acid—CHUK—Rac1/Pak1/p38/MMP-2 pathway—TP53—chronic obstructive pulmonary disease	8.43e-05	0.00121	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.41e-05	0.00121	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—chronic obstructive pulmonary disease	8.4e-05	0.0012	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	8.36e-05	0.0012	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	8.24e-05	0.00118	CbGpPWpGaD
Aminosalicylic Acid—CHUK—p75(NTR)-mediated signaling—TP53—chronic obstructive pulmonary disease	8.23e-05	0.00118	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Constitutive PI3K/AKT Signaling in Cancer—EGFR—chronic obstructive pulmonary disease	8.22e-05	0.00118	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TCR Signaling Pathway—TGFB1—chronic obstructive pulmonary disease	8.09e-05	0.00116	CbGpPWpGaD
Aminosalicylic Acid—Nausea—Prednisone—chronic obstructive pulmonary disease	8.07e-05	0.00116	CcSEcCtD
Aminosalicylic Acid—PTGS2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	8.04e-05	0.00115	CbGpPWpGaD
Aminosalicylic Acid—CHUK—MicroRNAs in cardiomyocyte hypertrophy—TNF—chronic obstructive pulmonary disease	7.98e-05	0.00114	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Apoptosis—TNF—chronic obstructive pulmonary disease	7.98e-05	0.00114	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	7.91e-05	0.00113	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—LEP—chronic obstructive pulmonary disease	7.79e-05	0.00112	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	7.73e-05	0.00111	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	7.73e-05	0.00111	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—RAPGEF3—chronic obstructive pulmonary disease	7.72e-05	0.00111	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Selenium Micronutrient Network—ALB—chronic obstructive pulmonary disease	7.71e-05	0.00111	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Regulation of toll-like receptor signaling pathway—CXCL8—chronic obstructive pulmonary disease	7.66e-05	0.0011	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	7.65e-05	0.0011	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—TLR4—chronic obstructive pulmonary disease	7.63e-05	0.00109	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—LY96—chronic obstructive pulmonary disease	7.51e-05	0.00108	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TNF alpha Signaling Pathway—TNF—chronic obstructive pulmonary disease	7.42e-05	0.00106	CbGpPWpGaD
Aminosalicylic Acid—CHUK—PI-3K cascade—EGFR—chronic obstructive pulmonary disease	7.41e-05	0.00106	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	7.4e-05	0.00106	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Regulation of toll-like receptor signaling pathway—IL1B—chronic obstructive pulmonary disease	7.35e-05	0.00105	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—NOS2—chronic obstructive pulmonary disease	7.26e-05	0.00104	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—ERBB3—chronic obstructive pulmonary disease	7.24e-05	0.00104	CbGpPWpGaD
Aminosalicylic Acid—CHUK—PI3K/AKT activation—EGFR—chronic obstructive pulmonary disease	7.23e-05	0.00104	CbGpPWpGaD
Aminosalicylic Acid—CHUK—GAB1 signalosome—EGFR—chronic obstructive pulmonary disease	7.17e-05	0.00103	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—chronic obstructive pulmonary disease	7.16e-05	0.00103	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TRAF6 Mediated Induction of proinflammatory cytokines—IL6—chronic obstructive pulmonary disease	7.05e-05	0.00101	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Apoptosis—TP53—chronic obstructive pulmonary disease	7.04e-05	0.00101	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Role of LAT2/NTAL/LAB on calcium mobilization—EGFR—chronic obstructive pulmonary disease	7.01e-05	0.00101	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—MMP9—chronic obstructive pulmonary disease	6.85e-05	0.000983	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll-like Receptor Signaling Pathway—TNF—chronic obstructive pulmonary disease	6.83e-05	0.00098	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—APIP—chronic obstructive pulmonary disease	6.73e-05	0.000965	CbGpPWpGaD
Aminosalicylic Acid—CHUK—MyD88 cascade initiated on plasma membrane—IL6—chronic obstructive pulmonary disease	6.38e-05	0.000915	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—chronic obstructive pulmonary disease	6.32e-05	0.000906	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	6.28e-05	0.0009	CbGpPWpGaD
Aminosalicylic Acid—CHUK—MyD88 dependent cascade initiated on endosome—IL6—chronic obstructive pulmonary disease	6.2e-05	0.00089	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TCR Signaling Pathway—IL6—chronic obstructive pulmonary disease	6.09e-05	0.000874	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TNF alpha Signaling Pathway—IL6—chronic obstructive pulmonary disease	5.99e-05	0.000859	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll Like Receptor 9 (TLR9) Cascade—IL6—chronic obstructive pulmonary disease	5.99e-05	0.000859	CbGpPWpGaD
Aminosalicylic Acid—CHUK—MyD88:Mal cascade initiated on plasma membrane—IL6—chronic obstructive pulmonary disease	5.89e-05	0.000844	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—TLR2—chronic obstructive pulmonary disease	5.86e-05	0.00084	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	5.82e-05	0.000835	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	5.74e-05	0.000823	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—ALB—chronic obstructive pulmonary disease	5.72e-05	0.00082	CbGpPWpGaD
Aminosalicylic Acid—CHUK—MyD88-independent cascade—IL6—chronic obstructive pulmonary disease	5.65e-05	0.00081	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—EGFR—chronic obstructive pulmonary disease	5.54e-05	0.000794	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll-like Receptor Signaling Pathway—IL6—chronic obstructive pulmonary disease	5.51e-05	0.000791	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—KL—chronic obstructive pulmonary disease	5.51e-05	0.00079	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—NOS3—chronic obstructive pulmonary disease	5.47e-05	0.000785	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.46e-05	0.000783	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—GCLC—chronic obstructive pulmonary disease	5.4e-05	0.000774	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—APIP—chronic obstructive pulmonary disease	5.34e-05	0.000766	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Regulation of toll-like receptor signaling pathway—TNF—chronic obstructive pulmonary disease	5.33e-05	0.000765	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling of activated FGFR—EGFR—chronic obstructive pulmonary disease	5.3e-05	0.00076	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—KL—chronic obstructive pulmonary disease	5.29e-05	0.000758	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by Interleukins—IL6—chronic obstructive pulmonary disease	5.27e-05	0.000755	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—EGFR—chronic obstructive pulmonary disease	5.24e-05	0.000752	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—EGFR—chronic obstructive pulmonary disease	5.21e-05	0.000748	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—CXCL8—chronic obstructive pulmonary disease	5.17e-05	0.000742	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Activated TLR4 signalling—IL6—chronic obstructive pulmonary disease	5.08e-05	0.000729	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	5.03e-05	0.000722	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	4.99e-05	0.000716	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—EGFR—chronic obstructive pulmonary disease	4.98e-05	0.000714	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—IL1B—chronic obstructive pulmonary disease	4.96e-05	0.000712	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—EGFR—chronic obstructive pulmonary disease	4.95e-05	0.000711	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—EGFR—chronic obstructive pulmonary disease	4.93e-05	0.000707	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—CTGF—chronic obstructive pulmonary disease	4.93e-05	0.000706	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—EGFR—chronic obstructive pulmonary disease	4.91e-05	0.000704	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling events of B Cell Receptor (BCR)—EGFR—chronic obstructive pulmonary disease	4.84e-05	0.000694	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	4.83e-05	0.000692	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	4.8e-05	0.000688	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll Like Receptor 4 (TLR4) Cascade—IL6—chronic obstructive pulmonary disease	4.78e-05	0.000685	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—MMP9—chronic obstructive pulmonary disease	4.68e-05	0.000671	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	4.63e-05	0.000664	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—EGFR—chronic obstructive pulmonary disease	4.62e-05	0.000662	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—EGFR—chronic obstructive pulmonary disease	4.62e-05	0.000662	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—EGFR—chronic obstructive pulmonary disease	4.62e-05	0.000662	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—EGFR—chronic obstructive pulmonary disease	4.57e-05	0.000656	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	4.55e-05	0.000653	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.54e-05	0.000651	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—EGFR—chronic obstructive pulmonary disease	4.53e-05	0.00065	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—EGFR—chronic obstructive pulmonary disease	4.51e-05	0.000647	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.46e-05	0.000639	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	4.43e-05	0.000635	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	4.42e-05	0.000634	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—TP53—chronic obstructive pulmonary disease	4.4e-05	0.000631	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	4.34e-05	0.000623	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—GC—chronic obstructive pulmonary disease	4.33e-05	0.000622	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Regulation of toll-like receptor signaling pathway—IL6—chronic obstructive pulmonary disease	4.3e-05	0.000617	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—EGFR—chronic obstructive pulmonary disease	4.27e-05	0.000613	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—CD8A—chronic obstructive pulmonary disease	4.26e-05	0.000611	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll-Like Receptors Cascades—IL6—chronic obstructive pulmonary disease	4.26e-05	0.00061	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—IL6—chronic obstructive pulmonary disease	4.26e-05	0.00061	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—IL1B—chronic obstructive pulmonary disease	4.2e-05	0.000602	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	4.14e-05	0.000593	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—ERBB3—chronic obstructive pulmonary disease	4.13e-05	0.000592	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—EGFR—chronic obstructive pulmonary disease	4.09e-05	0.000586	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling of activated FGFR—IL6—chronic obstructive pulmonary disease	4.07e-05	0.000584	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.03e-05	0.000578	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—IL6—chronic obstructive pulmonary disease	4.01e-05	0.000575	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—ERBB3—chronic obstructive pulmonary disease	3.96e-05	0.000568	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—TGFB1—chronic obstructive pulmonary disease	3.86e-05	0.000553	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—IL6—chronic obstructive pulmonary disease	3.83e-05	0.000549	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—IL6—chronic obstructive pulmonary disease	3.81e-05	0.000546	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.81e-05	0.000546	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—IL6—chronic obstructive pulmonary disease	3.79e-05	0.000544	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.78e-05	0.000543	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	3.78e-05	0.000543	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—EGFR—chronic obstructive pulmonary disease	3.78e-05	0.000542	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—CRP—chronic obstructive pulmonary disease	3.77e-05	0.000541	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—IL6—chronic obstructive pulmonary disease	3.77e-05	0.000541	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.73e-05	0.000535	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	3.68e-05	0.000527	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	3.65e-05	0.000523	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—TLR4—chronic obstructive pulmonary disease	3.62e-05	0.000519	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—TNF—chronic obstructive pulmonary disease	3.6e-05	0.000517	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—IL6—chronic obstructive pulmonary disease	3.55e-05	0.000509	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—IL6—chronic obstructive pulmonary disease	3.55e-05	0.000509	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—IL6—chronic obstructive pulmonary disease	3.55e-05	0.000509	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.54e-05	0.000507	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—IL6—chronic obstructive pulmonary disease	3.52e-05	0.000504	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.51e-05	0.000503	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—IL6—chronic obstructive pulmonary disease	3.48e-05	0.0005	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.48e-05	0.000499	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—IL6—chronic obstructive pulmonary disease	3.47e-05	0.000498	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—GC—chronic obstructive pulmonary disease	3.44e-05	0.000493	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—TLR2—chronic obstructive pulmonary disease	3.41e-05	0.000489	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.3e-05	0.000473	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.21e-05	0.00046	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—KL—chronic obstructive pulmonary disease	3.21e-05	0.00046	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.2e-05	0.000459	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—HDAC2—chronic obstructive pulmonary disease	3.18e-05	0.000457	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—TP53—chronic obstructive pulmonary disease	3.18e-05	0.000455	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—EGFR—chronic obstructive pulmonary disease	3.14e-05	0.000451	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—IL6—chronic obstructive pulmonary disease	3.14e-05	0.000451	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	3.05e-05	0.000437	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—KL—chronic obstructive pulmonary disease	2.96e-05	0.000425	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—IL6—chronic obstructive pulmonary disease	2.91e-05	0.000417	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	2.86e-05	0.00041	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	2.62e-05	0.000376	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CD8A—chronic obstructive pulmonary disease	2.58e-05	0.000371	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	2.57e-05	0.000369	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.55e-05	0.000366	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—IL6—chronic obstructive pulmonary disease	2.46e-05	0.000353	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	2.45e-05	0.000351	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—IL6—chronic obstructive pulmonary disease	2.42e-05	0.000347	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—ERBB3—chronic obstructive pulmonary disease	2.4e-05	0.000345	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.37e-05	0.00034	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.34e-05	0.000336	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—ALB—chronic obstructive pulmonary disease	2.24e-05	0.000321	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.23e-05	0.00032	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—ERBB3—chronic obstructive pulmonary disease	2.22e-05	0.000318	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CRP—chronic obstructive pulmonary disease	2.2e-05	0.000315	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.18e-05	0.000313	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	2.16e-05	0.00031	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—NOS3—chronic obstructive pulmonary disease	2.14e-05	0.000307	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—CTGF—chronic obstructive pulmonary disease	2.14e-05	0.000306	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—TLR4—chronic obstructive pulmonary disease	2.11e-05	0.000302	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.07e-05	0.000297	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.97e-05	0.000282	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.91e-05	0.000274	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—HDAC2—chronic obstructive pulmonary disease	1.89e-05	0.000271	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.88e-05	0.00027	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—GCLC—chronic obstructive pulmonary disease	1.86e-05	0.000266	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—NOS2—chronic obstructive pulmonary disease	1.85e-05	0.000265	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—EGFR—chronic obstructive pulmonary disease	1.79e-05	0.000257	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—KL—chronic obstructive pulmonary disease	1.75e-05	0.000252	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.73e-05	0.000248	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—EGFR—chronic obstructive pulmonary disease	1.72e-05	0.000247	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.71e-05	0.000245	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CTGF—chronic obstructive pulmonary disease	1.7e-05	0.000243	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.64e-05	0.000235	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.62e-05	0.000232	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.56e-05	0.000224	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—SERPINE1—chronic obstructive pulmonary disease	1.56e-05	0.000223	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.55e-05	0.000223	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.51e-05	0.000216	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.5e-05	0.000215	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—NOS3—chronic obstructive pulmonary disease	1.49e-05	0.000213	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.43e-05	0.000205	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.39e-05	0.000199	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—IL6—chronic obstructive pulmonary disease	1.38e-05	0.000198	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IL1B—chronic obstructive pulmonary disease	1.37e-05	0.000197	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—ERBB3—chronic obstructive pulmonary disease	1.31e-05	0.000189	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.3e-05	0.000187	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.28e-05	0.000184	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.2e-05	0.000172	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.13e-05	0.000163	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—NOS2—chronic obstructive pulmonary disease	1.1e-05	0.000157	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.09e-05	0.000156	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—EGFR—chronic obstructive pulmonary disease	1.04e-05	0.00015	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.04e-05	0.000149	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—TGFB1—chronic obstructive pulmonary disease	9.84e-06	0.000141	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—ALB—chronic obstructive pulmonary disease	9.72e-06	0.000139	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—EGFR—chronic obstructive pulmonary disease	9.64e-06	0.000138	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—NOS3—chronic obstructive pulmonary disease	9.3e-06	0.000133	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	9.24e-06	0.000133	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—SERPINE1—chronic obstructive pulmonary disease	9.23e-06	0.000132	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—NOS3—chronic obstructive pulmonary disease	8.81e-06	0.000126	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	8.36e-06	0.00012	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IL6—chronic obstructive pulmonary disease	8.03e-06	0.000115	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—ALB—chronic obstructive pulmonary disease	7.71e-06	0.000111	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	7.5e-06	0.000108	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—IL6—chronic obstructive pulmonary disease	7.41e-06	0.000106	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—NOS3—chronic obstructive pulmonary disease	7.38e-06	0.000106	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	6.89e-06	9.88e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	6.75e-06	9.69e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—TGFB1—chronic obstructive pulmonary disease	5.83e-06	8.36e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—EGFR—chronic obstructive pulmonary disease	5.71e-06	8.19e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.67e-06	8.13e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IL6—chronic obstructive pulmonary disease	5.19e-06	7.44e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—IL6—chronic obstructive pulmonary disease	4.39e-06	6.3e-05	CbGpPWpGaD
